This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

FTC asks Third Circuit to revive antitrust case against Shire

( June 19, 2018, 22:31 GMT | Official Statement) -- MLex Summary: The US Federal Trade Commission filed an opening brief in its appeal of an order that dismissed its claims alleging Shire ViroPharma abused the US Food and Drug Administration's citizen petition process to maintain its monopoly on Vancocin. The FTC says the district court should have applied “the established likelihood-of-recurrence standard to assess the sufficiency of the complaint and under the correct legal standards, the complaint states a claim for both injunctive relief and for equitable monetary relief.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections